| View |
|
BRP-057-03
|
Human Albumin
|
Hulbumine
|
20% (0.2 g/mL)
|
Solution For Intravenous Infusion
|
Blood substitutes and plasma protein fractions
|
Reliance Life Sciences Pvt. Ltd.
|
India
|
Renewal
|
14 January 2024
|
09 May 2029
|
| View |
BRP-059_PI_01.pdf
|
BRP-059
|
Insulin Glargine
|
Basaglar Kwikpen
|
100 Units/mL
|
Solution For Injection (SC)
|
-
|
Eli Lilly Italia S.p.A.
|
Italy
|
Monitored Release (Variation)
|
21 November 2022
|
21 November 2027
|
| View |
|
BRP-060
|
Enoxaparin Sodium
|
Enoxane
|
4,000 IU Anti-Factor Xa (equivalent to 40mg) / 0.4mL
|
Solution for Injection (I.V./S.C.)
|
Antithrombotic
|
Hebei Changshan Biochemical Pharmaceutical Company Ltd.
|
China
|
Automatic Renewal
|
31 July 2021
|
02 September 2026
|
| View |
|
BRP-062
|
Enoxaparin Sodium
|
Enoxane
|
6,000 IU Anti-Factor Xa (equivalent to 60mg) / 0.6mL
|
Solution for Injection (I.V./S.C.)
|
Antithrombotic
|
Hebei Changshan Biochemical Pharmaceutical Company Ltd.
|
China
|
Automatic Renewal
|
31 July 2021
|
02 September 2026
|
| View |
|
BRP-063
|
Enoxaparin Sodium
|
Bnoxaparin
|
20 mg/0.2 mL
|
Solution For Injection (Iv/SC)
|
Antithrombotic Agent
|
Brawn Laboratories Limited
|
India
|
Renewal
|
14 April 2023
|
15 August 2026
|
| View |
|
BRP-063-01
|
Enoxaparin Sodium
|
Goxaparin
|
20 mg/0.2 mL
|
Solution For Injection (I.V/S.C)
|
Antithrombotic Agent
|
Brawn Laboratories Limited
|
India
|
Automatic Renewal
|
02 July 2023
|
15 August 2026
|
| View |
|
BRP-065
|
Isophane Insulin Human
|
Biosulidd N
|
100 IU/mL (100% Isophane Insulin Human)
|
Suspension for Injection (IM/SC)
|
Antidiabetics
|
M.J. Biopharm Pvt., Ltd.
|
India
|
-
|
16 November 2021
|
28 August 2026
|
| View |
|
BRP-065-01
|
Insulin Human (rDNA)
|
Lupinsulin N
|
100 IU/mL (100% Isophane Insulin Human)
|
Suspension for Injection (IM/SC)
|
-
|
M.J. Biopharm Pvt., Ltd.
|
India
|
-
|
16 November 2021
|
28 August 2026
|
| View |
|
BRP-066
|
Insulin Human (rDNA)
|
Biosulidd R
|
100 IU/ ML
|
Solution for Injection (IM/SC)
|
-
|
M.J. Biopharm Pvt. Ltd.
|
India
|
-
|
07 March 2022
|
05 June 2026
|
| View |
|
BRP-066-01
|
Insulin Human (rDNA)
|
Lupinsulin R
|
100 IU/mL
|
Solution for Injection (IM/SC)
|
-
|
MJ Biopharm Pvt. Ltd.
|
India
|
-
|
14 December 2021
|
05 June 2026
|
| View |
|
BRP-067
|
Epoetin Alfa
|
Pronivel
|
4,000 IU/mL
|
Solution for Injection (IV/SC)
|
Hematopoietic Growth Factor
|
M.R. Pharma S.A. (Building I)
|
Argentina
|
Automatic Renewal
|
03 October 2022
|
25 January 2028
|
| View |
|
BRP-068
|
Filgrastim
|
Colstim
|
300 mcg/mL
|
Solution For Injection (IV/SC)
|
-
|
Cadila Healthcare Limited
|
India
|
-
|
29 April 2022
|
02 February 2026
|
| View |
|
BRP-070
|
Peginterferon Alfa-2B
|
Pegihep 80
|
80 mcg
|
Powder For Solution For Injection (Sc)
|
-
|
Cadila Healthcare Limited
|
India
|
-
|
18 March 2022
|
11 March 2026
|
| View |
|
BRP-072
|
Botulinum Toxin Type A (from clostridium botulinum)
|
Nabota
|
50 units
|
Lyophilized Powder For Injection (IM/SC)
|
Muscle Relaxant
|
Daewoong Pharmaceutical Co., Ltd.
|
Korea
|
Automatic Renewal
|
29 July 2022
|
17 August 2027
|
| View |
|
BRP-074-01
|
Insulin Human (rDNA)
|
Lupinsulin 30:70
|
100 IU/mL Suspension for Injection (IM/SC) (30% Soluble Insulin Human / 70% Isophane Insulin
Human)
|
Suspension for Injection (IM/SC)
|
Antidiabetic agents
|
M.J. Biopharm Pvt., Ltd.
|
India
|
Renewal
|
05 May 2022
|
23 February 2027
|
| View |
|
BRP-075
|
Epoetin Alfa (Recombinant Human Erythropoietin)
|
Aropotin
|
2000 IU/ 0.5 mL
|
Solution for Injection (IV/SC)
|
Antianemic Preparations
|
HK Bioinnovation Co., Ltd
|
Korea
|
Renewal
|
23 July 2021
|
23 August 2026
|
| View |
|
BRP-076-01
|
Epoetin Alfa (Recombinant Human Erythropoietin)
|
Epolitt
|
4,000 IU
|
Solution For Injection
|
-
|
TS Corporation
|
Korea
|
Renewal
|
21 September 2021
|
23 August 2026
|
| View |
|
BRP-076-02
|
Epoetin Alfa
|
Eprotex
|
4000 IU / 0.5mL
|
Solution For Injection(IV/SC)
|
Hematopoietic Growth Factors
|
HK Bioinnovation Co., Ltd
|
Korea
|
Compliance - RNW
|
29 March 2022
|
23 August 2026
|
| View |
|
BRP-076-03
|
Epoetin Alfa
|
Eprosenz
|
4000 IU/0.5mL
|
Solution For Injection (IV/SC)
|
Hematopoietic Growth Factors
|
HK Bioinnovation Co., Ltd
|
Korea
|
Compliance - RNW
|
29 March 2022
|
23 August 2026
|
| View |
|
BRP-076-04
|
Epoetin Alfa (Recombinant Human Erythropoietin)
|
Ematep
|
4000 IU/0.5 mL
|
Solution For Injection (Iv/Sc)
|
-
|
TS Corporation
|
Korea
|
Renewal
|
17 September 2021
|
23 August 2026
|